Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
企業コードENOV
会社名Enovis Corp
上場日May 08, 2008
最高経営責任者「CEO」Mr. Damien Mcdonald
従業員数7367
証券種類Ordinary Share
決算期末May 08
本社所在地2711 Centerville Road
都市WILMINGTON
証券取引所NYSE Consolidated
国United States of America
郵便番号19808
電話番号13022529160
ウェブサイトhttps://www.enovis.com/
企業コードENOV
上場日May 08, 2008
最高経営責任者「CEO」Mr. Damien Mcdonald
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし